SCHEMBL7612899

SCHEMBL7612899

O=C(NCc1ccc(Br)cc1)c1cccc(NC(=O)c2ccccc2-c2ccccc2)c1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SENP1 Q9P0U3 3/20 0.64
HTT P42858 3/20 0.63
ALDH1A1 P00352 3/20 0.63
CHRNB2 P17787 2/20 0.56
CHRNB4 P30926 2/20 0.56
CHRNA3 P32297 2/20 0.56
CHRNA4 P43681 2/20 0.56
PPARG P37231 2/20 0.56
HPGD P15428 1/20 0.55
LMNA P02545 2/20 0.54
MAPK1 P28482 1/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
EPHX2 P34913 1/20 0.51
NR1H4 Q96RI1 1/20 0.51
KDM4E B2RXH2 1/20 0.51
GAA P10253 1/20 0.51
MEN1 O00255 1/20 0.50
TP53 P04637 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610932 0.92 CHRNB2 (0.60) SENP1HTTALDH1A1CHRNB2CHRNB4
SCHEMBL7607114 0.90 CHRNB2 (0.58) SENP1HTTALDH1A1CHRNB2CHRNB4
SCHEMBL7613182 0.90 CHRNB2 (0.57) SENP1HTTALDH1A1CHRNB2CHRNB4
SCHEMBL7607434 0.89 SENP1 (0.56) SENP1HTTALDH1A1PPARGGAA
SCHEMBL7611172 0.88 HTT (0.57) SENP1HTTALDH1A1CHRNB2CHRNB4
SCHEMBL7607213 0.87 HTT (0.61) SENP1HTTALDH1A1CHRNB2CHRNB4
SCHEMBL7610512 0.87 L3MBTL1 (0.61) SENP1HTTALDH1A1CHRNB2CHRNB4
SCHEMBL7609244 0.86 HTT (0.55) SENP1HTTALDH1A1CHRNB2CHRNB4
SCHEMBL7606402 0.85 MTTP (0.57) SENP1HTTALDH1A1CHRNB2CHRNB4
SCHEMBL7609363 0.85 MTTP (0.57) SENP1HTTALDH1A1CHRNB2CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments MTTP, CETP, FABP1 SENP1 2064/4885HTT 3107/4885ALDH1A1 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.